Women more likely to take part in clinical trials they discover through peers

March 10, 2017

Women are often underrepresented in HIV clinical trials, making it difficult to decipher the relevance of findings and whether they are applicable to all.

Coinciding with National Women and Girls HIV/AIDS Awareness Day, new data published today in the Taylor & Francis journal HIV Clinical Trials uncovers how an evidence-based campaign, Follow YOUR Heart, is empowering older women with HIV to participate in a large-scale clinical trial aimed at preventing cardiovascular disease, the REPRIEVE trial.

Massachusetts General Hospital and Harvard Medical School researchers Dr Sara Looby and Dr. Markella Zanni uncovered women's preferred methods for learning about a trial were peer-to-peer communication (52% of those questioned), provider communication (46%) and video-based communication (39%). Women were most likely to take part to gain information (63%) and to help others (47%).

Dr. Looby and Dr. Zanni commented: "Feedback from our community sample of women offered valuable perspectives on methods to help educate and engage women with HIV on research participation, making our Follow YOUR Heart campaign truly patient-centered."

Explore further: Better health for women involved in clinical trials

More information: Markella V. Zanni et al. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial, HIV Clinical Trials (2017). DOI: 10.1080/15284336.2017.1297551

Related Stories

Better health for women involved in clinical trials

February 14, 2017

Women who participate in obstetric and gynaecology clinical trials experience improved health outcomes compared to those who are not involved in trials, according to research by Queen Mary University of London (QMUL). This ...

Most women feel PCPs are involved in breast cancer care

October 10, 2016

(HealthDay)—Most women newly diagnosed with breast cancer perceive high primary care provider (PCP) quality, and report that their PCPs have high engagement and communication, according to research published online Oct. ...

Results from the PLATINUM DIVERSITY study presented

November 1, 2016

A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients. Although there ...

Type 2 diabetes drug trials unnecessarily exclude women

May 5, 2016

While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn ...

Recommended for you

Scientists zoom in on AIDS virus hideout

March 15, 2017

French scientists said Wednesday they had found a way to pinpoint elusive white blood cells which provide a hideout for the AIDS virus in people taking anti-HIV drugs.

HIV hijacks common cells to spread infection

February 16, 2017

Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), together with collaborators in Europe, discovered that a common type of cell within the human reproductive and intestinal tracts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.